The launch of BrightMeds GLP-1 marks a crucial shift in how healthcare providers manage type 2 diabetes . This new medication category provides a distinctive method that also lowers sugar but may encourage a reduction in weight and enhance cardiovascular outcomes. Early data suggest this therapy